Lower cognitive performance in healthy G2019S LRRK2 mutation carriers.
about
Progressive degeneration of human neural stem cells caused by pathogenic LRRK2Parkinson Disease and Dementia.The neurobiological basis of cognitive impairment in Parkinson's disease.The spectrum of cognitive impairment in Lewy body diseasesReorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers.Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 geneIncrease in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife.Heterozygous deletion of the LRFN2 gene is associated with working memory deficits.Hyperbaric oxygen can induce neuroplasticity and improve cognitive functions of patients suffering from anoxic brain damage.LRRK2: cause, risk, and mechanism.Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson's DiseaseCognitive decline in Parkinson disease.Human LRRK2 G2019S mutation represses post-synaptic protein PSD95 and causes cognitive impairment in transgenic miceA cognitive fMRI study in non-manifesting LRRK2 and GBA carriers.Association between Parkinson's disease and G2019S and R1441C mutations of the LRRK2 gene.Clinical Features of LRRK2 Carriers with Parkinson's Disease.White matter correlates of cognitive domains in normal aging with diffusion tensor imagingHyperbaric Oxygen Therapy Can Induce Angiogenesis and Regeneration of Nerve Fibers in Traumatic Brain Injury Patients.Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.Cognitive changes in prodromal Parkinson's disease: A review.DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease.Intact working memory in non-manifesting LRRK2 carriers--an fMRI study.Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism.Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adults.Fasting plasma glucose in young adults free of diabetes is associated with cognitive function in midlife.Hyperbaric oxygen may induce angiogenesis in patients suffering from prolonged post-concussion syndrome due to traumatic brain injury.Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease.Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?Cognition among individuals along a spectrum of increased risk for Parkinson's disease
P2860
Q24301070-CB17991E-F29A-4807-83E5-7EA307228A57Q30248574-A21A7CE4-4FFD-42BB-A50A-204248AA69DFQ33724698-6F016DC3-825D-4AB4-9826-687B76B88F80Q34019751-ADF7BE87-7DAC-41EB-9EA3-27C19D57E5AEQ35106295-262A460B-2DD1-45D6-A93C-2FD8449FB8C6Q35772821-DAACAAF5-C2CB-4319-9E3E-3A7EA7D11FA5Q35787860-2056BA44-96BF-4098-8AE6-71D2A0C3B851Q36902733-4B68F3AF-4E0A-497B-BFE6-6ACB4B0DD277Q37044137-BF5E536E-DAD6-4463-97CE-6697BEC38A3AQ37635000-3D40B92A-A8F3-4475-9AD7-811792449CA7Q38384109-4A086DFA-5C77-4411-A9F3-D3EC8066DE65Q38751099-FCF06B5B-66B1-4EB4-BF09-CFAC85674BC4Q38795375-C484338F-6C01-4C9C-AF62-B0AB7E7CFCFAQ38843010-DCD6CC18-373F-4BBA-B1D5-7C281A54E211Q38936883-FAD1ECD5-F686-4D0B-A7B5-264F7D74E6E8Q39206423-317A8534-D6A9-4DE7-ADB2-32EAA00D2A01Q41215485-7A649A21-366B-4733-A8A8-86FDC4DDC920Q43260567-3801560B-FE3C-4FBA-BD32-B4029377E58EQ47555107-788C7C25-AB4A-4B5F-9FCD-F06F9BDCAAC2Q47860019-22B062CC-F51C-4BCD-9460-7B3E3330592FQ47907932-0A34D89B-2371-4734-9FC7-272B3E76EB05Q47972063-6FBFDE2E-996B-4F33-B8BE-F8EFCB0A9FF1Q48192270-EE9F7B77-82C2-42DD-B52D-D293E402D8DAQ48248911-0D5F165C-8EC0-4E26-94A6-92885CD6A105Q48878610-E1B48AA1-60BA-4943-91BA-B3E168113F0FQ50000495-4E287424-F6DE-4057-BB51-3091784C3DD0Q52147745-A7574625-20EA-40AB-9C90-21AC19AD6BABQ53397478-11BF86B4-C0F2-40A6-B6BE-4081E686FE92Q54403187-9A077AFB-DD32-4EFB-8C11-2E0E6C40194CQ54982491-A20393F2-8167-400F-A9D4-B755C1A2311AQ57168544-600A3870-EC4F-4D17-885E-5D2532550984
P2860
Lower cognitive performance in healthy G2019S LRRK2 mutation carriers.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Lower cognitive performance in healthy G2019S LRRK2 mutation carriers.
@ast
Lower cognitive performance in healthy G2019S LRRK2 mutation carriers.
@en
type
label
Lower cognitive performance in healthy G2019S LRRK2 mutation carriers.
@ast
Lower cognitive performance in healthy G2019S LRRK2 mutation carriers.
@en
prefLabel
Lower cognitive performance in healthy G2019S LRRK2 mutation carriers.
@ast
Lower cognitive performance in healthy G2019S LRRK2 mutation carriers.
@en
P2093
P2860
P50
P1433
P1476
Lower cognitive performance in healthy G2019S LRRK2 mutation carriers.
@en
P2093
Anat Mirelman
Avner Thaler
Karen Marder
LRRK2 Ashkenazi Jewish Consortium
Susan Bressman
Tanya Gurevich
P2860
P304
P356
10.1212/WNL.0B013E3182684646
P407
P577
2012-08-22T00:00:00Z